Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
27 | 4 | OPHTHALMOLOGY//OPHTHALMOL//JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 152618 |
8 | 3 | OPHTHALMOLOGY//OPHTHALMOL//JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 152618 |
1964 | 2 | ADENO ASSOCIATED VIRUS//PEDF//PIGMENT EPITHELIUM DERIVED FACTOR | 6062 |
936 | 1 | ADENO ASSOCIATED VIRUS//AAV//POWELL GENE THER Y | 2986 |
7162 | 1 | CORNEAL TRANSPLANTATION//IMMUNE PRIVILEGE//ACAID | 1426 |
15854 | 1 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF | 715 |
16602 | 1 | CORNEAL NEOVASCULARIZATION//HEMANGIOGENESIS//NEOVASCULARIZATION | 671 |
26837 | 1 | THERAPEUTIC TRANSGENES//ABT MED MOLEKULARGENET GENDIAGNOST//ANTERIOR SEGMENT CELLS | 264 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ADENO ASSOCIATED VIRUS | authKW | 929584 | 8% | 38% | 469 |
2 | PEDF | authKW | 613613 | 3% | 72% | 163 |
3 | PIGMENT EPITHELIUM DERIVED FACTOR | authKW | 601348 | 3% | 74% | 157 |
4 | CORNEAL NEOVASCULARIZATION | authKW | 581969 | 3% | 67% | 168 |
5 | AAV | authKW | 569030 | 4% | 44% | 249 |
6 | POWELL GENE THER Y | address | 260242 | 2% | 39% | 128 |
7 | GENE THER Y | address | 220936 | 6% | 12% | 343 |
8 | CELLULAR MOL THER Y | address | 175345 | 1% | 50% | 68 |
9 | CORNEAL TRANSPLANTATION | authKW | 165470 | 2% | 25% | 128 |
10 | AAV VECTORS | authKW | 162450 | 1% | 51% | 61 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Ophthalmology | 65774 | 28% | 1% | 1706 |
2 | Medicine, Research & Experimental | 24235 | 24% | 0% | 1474 |
3 | Virology | 17060 | 13% | 0% | 792 |
4 | Biotechnology & Applied Microbiology | 14159 | 21% | 0% | 1294 |
5 | Genetics & Heredity | 13067 | 20% | 0% | 1221 |
6 | Transplantation | 1320 | 3% | 0% | 208 |
7 | Immunology | 1155 | 8% | 0% | 506 |
8 | Biochemistry & Molecular Biology | 792 | 14% | 0% | 844 |
9 | Hematology | 246 | 3% | 0% | 168 |
10 | Cell Biology | 149 | 5% | 0% | 288 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | POWELL GENE THER Y | 260242 | 2% | 39% | 128 |
2 | GENE THER Y | 220936 | 6% | 12% | 343 |
3 | CELLULAR MOL THER Y | 175345 | 1% | 50% | 68 |
4 | GENE THER Y PROGRAM | 124333 | 2% | 21% | 115 |
5 | EPENS EYE | 99071 | 3% | 12% | 165 |
6 | CELLULAR MOL THER EUT | 67551 | 1% | 33% | 40 |
7 | OPHTHALMOL | 66307 | 20% | 1% | 1195 |
8 | GENET THER EUT | 53739 | 1% | 24% | 44 |
9 | U649 | 53143 | 0% | 68% | 15 |
10 | UNC GENE THER Y | 50831 | 0% | 65% | 15 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 129908 | 5% | 9% | 291 |
2 | MOLECULAR THERAPY | 121863 | 5% | 8% | 294 |
3 | HUMAN GENE THERAPY METHODS | 99872 | 1% | 33% | 59 |
4 | GENE THERAPY | 91857 | 4% | 7% | 265 |
5 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 42011 | 7% | 2% | 400 |
6 | MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 36728 | 1% | 18% | 40 |
7 | CORNEA | 28084 | 3% | 3% | 175 |
8 | JOURNAL OF VIROLOGY | 25394 | 7% | 1% | 447 |
9 | JOURNAL OF GENE MEDICINE | 16119 | 1% | 5% | 67 |
10 | CURRENT GENE THERAPY | 15839 | 1% | 7% | 42 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENO ASSOCIATED VIRUS | 929584 | 8% | 38% | 469 | Search ADENO+ASSOCIATED+VIRUS | Search ADENO+ASSOCIATED+VIRUS |
2 | PEDF | 613613 | 3% | 72% | 163 | Search PEDF | Search PEDF |
3 | PIGMENT EPITHELIUM DERIVED FACTOR | 601348 | 3% | 74% | 157 | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR |
4 | CORNEAL NEOVASCULARIZATION | 581969 | 3% | 67% | 168 | Search CORNEAL+NEOVASCULARIZATION | Search CORNEAL+NEOVASCULARIZATION |
5 | AAV | 569030 | 4% | 44% | 249 | Search AAV | Search AAV |
6 | CORNEAL TRANSPLANTATION | 165470 | 2% | 25% | 128 | Search CORNEAL+TRANSPLANTATION | Search CORNEAL+TRANSPLANTATION |
7 | AAV VECTORS | 162450 | 1% | 51% | 61 | Search AAV+VECTORS | Search AAV+VECTORS |
8 | IMMUNE PRIVILEGE | 126537 | 1% | 27% | 89 | Search IMMUNE+PRIVILEGE | Search IMMUNE+PRIVILEGE |
9 | GENE THERAPY | 96028 | 9% | 4% | 524 | Search GENE+THERAPY | Search GENE+THERAPY |
10 | ACAID | 94738 | 0% | 65% | 28 | Search ACAID | Search ACAID |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |